WO2009044156A3 - Methods of identifying modulators of an ehd polypeptide - Google Patents

Methods of identifying modulators of an ehd polypeptide Download PDF

Info

Publication number
WO2009044156A3
WO2009044156A3 PCT/GB2008/003355 GB2008003355W WO2009044156A3 WO 2009044156 A3 WO2009044156 A3 WO 2009044156A3 GB 2008003355 W GB2008003355 W GB 2008003355W WO 2009044156 A3 WO2009044156 A3 WO 2009044156A3
Authority
WO
WIPO (PCT)
Prior art keywords
ehd
polypeptide
methods
modulator
samples
Prior art date
Application number
PCT/GB2008/003355
Other languages
French (fr)
Other versions
WO2009044156A2 (en
Inventor
Harvey Mcmahon
Gary Doherty
Richard Lundmark
Oli Daumke
Original Assignee
Medical Res Council
Harvey Mcmahon
Gary Doherty
Richard Lundmark
Oli Daumke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council, Harvey Mcmahon, Gary Doherty, Richard Lundmark, Oli Daumke filed Critical Medical Res Council
Priority to EP08806500A priority Critical patent/EP2205756A2/en
Priority to US12/680,347 priority patent/US20120214173A1/en
Publication of WO2009044156A2 publication Critical patent/WO2009044156A2/en
Publication of WO2009044156A3 publication Critical patent/WO2009044156A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a method of identifying a modulator of an EHD family polypeptide, said method comprising (i) providing a first and second sample of an EHD polypeptide; (ii) contacting said first sample with a candidate modulator; (iii) contacting said first and second samples with ATP; and (iv) monitoring ATP hydrolysis in said first and second samples, wherein a difference between the ATP hydrolysis in said first and second samples identifies said candidate modulator as a modulator of an EHD family polypeptide. The invention also relates to methods of modelling molecules and to various EHD mutant polypeptides.
PCT/GB2008/003355 2007-10-02 2008-10-01 Methods of identifying modulators of an ehd polypeptide WO2009044156A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP08806500A EP2205756A2 (en) 2007-10-03 2008-10-01 Methods of identifying modulators of an ehd polypeptide
US12/680,347 US20120214173A1 (en) 2007-10-02 2008-10-01 Methods of Identifying Modulators of an Ehd Polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0719252A GB2453341B (en) 2007-10-03 2007-10-03 Methods of identifying modulators of an EHD family polypeptide
GB0719252.9 2007-10-03

Publications (2)

Publication Number Publication Date
WO2009044156A2 WO2009044156A2 (en) 2009-04-09
WO2009044156A3 true WO2009044156A3 (en) 2009-07-23

Family

ID=38739010

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/003355 WO2009044156A2 (en) 2007-10-02 2008-10-01 Methods of identifying modulators of an ehd polypeptide

Country Status (3)

Country Link
EP (1) EP2205756A2 (en)
GB (1) GB2453341B (en)
WO (1) WO2009044156A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102787122B (en) * 2012-06-21 2013-06-19 南京农业大学 Gene OsEHD4 for controlling paddy rice heading stage and mutant and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020115069A1 (en) * 1997-02-21 2002-08-22 Mia Horowitz Eh domain containing genes and proteins
WO2003091390A2 (en) * 2001-11-14 2003-11-06 Digital Gene Technologies, Inc. Regulation of gene expression by neuromodulators and discovery of a novel ngf-induced protein termed pincher
WO2007079581A1 (en) * 2006-01-09 2007-07-19 University Of Manitoba Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carobxylase

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020115069A1 (en) * 1997-02-21 2002-08-22 Mia Horowitz Eh domain containing genes and proteins
WO2003091390A2 (en) * 2001-11-14 2003-11-06 Digital Gene Technologies, Inc. Regulation of gene expression by neuromodulators and discovery of a novel ngf-induced protein termed pincher
WO2007079581A1 (en) * 2006-01-09 2007-07-19 University Of Manitoba Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carobxylase

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
DAUMKE OLIVER ET AL: "Architectural and mechanistic insights into an EHD ATPase involved in membrane remodelling", NATURE (LONDON), vol. 449, no. 7164, 3 October 2007 (2007-10-03), pages 923, XP002529189, ISSN: 0028-0836 *
GEORGE M ET AL: "Shared as well as distinct roles of EHD proteins revealed by biochemical and functional comparisons in mammalian cells and C. elegans", BMC CELL BIOLOGY 2007 GB, vol. 8, 18 January 2007 (2007-01-18), XP002513318, ISSN: 1471-2121 *
GUILHERME ADILSON ET AL: "Role of EHD1 and EHBP1 in perinuclear sorting and insulin-regulated GLUT4 recycling in 3T3-L1 adipocytes.", THE JOURNAL OF BIOLOGICAL CHEMISTRY 17 SEP 2004, vol. 279, no. 38, 17 September 2004 (2004-09-17), pages 40062 - 40075, XP002513317, ISSN: 0021-9258 *
KIEKEN FABIEN ET AL: "EH domain of EHD1", JOURNAL OF BIOMOLECULAR NMR, vol. 39, no. 4, 26 September 2007 (2007-09-26), pages 323 - 329, XP019553160, ISSN: 0925-2738 *
LEACH A: "Molecular Modelling, Principles and Applications; The use of molecular modelling and chemoinformatics to discover and design new molecules", 1 January 2001, MOLECULAR MODELLING: PRINCIPLES AND APPLICATIONS, XX, XX, PAGE(S) 640 - 726, XP002444241 *
LEE D -W ET AL: "ATP binding regulates oligomerization and endosome association of RME-1 family proteins", JOURNAL OF BIOLOGICAL CHEMISTRY 20050429 US, vol. 280, no. 17, 29 April 2005 (2005-04-29), pages 17213 - 17220, XP002513315, ISSN: 0021-9258 *
MONTESINOS ET AL: "Recycling and EH domain proteins at the synapse", BRAIN RESEARCH REVIEWS, ELSEVIER, vol. 49, no. 2, 1 September 2005 (2005-09-01), pages 416 - 428, XP005029083, ISSN: 0165-0173 *
NASLAVSKY N ET AL: "C-terminal EH-domain-containing proteins: Consensus for a role in endocytic trafficking, EH?", JOURNAL OF CELL SCIENCE 20050915 GB, vol. 118, no. 18, 15 September 2005 (2005-09-15), pages 4093 - 4101, XP002513319, ISSN: 0021-9533 *
PARK S Y ET AL: "EHD2 interacts with the insulin-responsive glucose transporter (GLUT4) in rat adipocytes and may participate in insulin-induced GLUT4 recruitment", BIOCHEMISTRY 20040615 US, vol. 43, no. 23, 15 June 2004 (2004-06-15), pages 7552 - 7562, XP002513316, ISSN: 0006-2960 *

Also Published As

Publication number Publication date
GB2453341B (en) 2010-08-25
GB2453341A (en) 2009-04-08
EP2205756A2 (en) 2010-07-14
GB0719252D0 (en) 2007-11-14
WO2009044156A2 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
WO2008039996A3 (en) Multi-detector gas identification system
EP2315034A3 (en) Means and methods for assessing the risk of cardiac interventions based on GDF-15
WO2006116362A3 (en) Structured substrates for optical surface profiling
WO2006098752A3 (en) Ultrasensitive sensor and rapid detection of analytes
WO2005071110A3 (en) Improving polynucleotide ligation reactions
WO2007114986A3 (en) Cooperative probes and methods of using them
WO2010033452A3 (en) Mono-and multi-element coded libs assays and methods
WO2007140291A3 (en) Expression quantification using mass spectrometry
EP2333116A3 (en) Markers of renal transplant rejection and renal damage
WO2006071903A3 (en) Cell based methods and systems for the identification of rna regulatory sequences and compounds that modulate their functions
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
WO2009018307A3 (en) Analysis of polypeptide production
WO2007136980A3 (en) Diagnostic test media and methods for the manufacture thereof
WO2008008919A3 (en) Methods and systems for sequence-based design of multiple reaction monitoring transitions and experiments
WO2015035239A3 (en) Reagents and methods for screening mps i, ii, iiia, iiib, iva, vi, and vii
WO2012162373A8 (en) Ros kinase in lung cancer
TW200612092A (en) System and method for flow analysis or flow injection analysis
WO2009126848A3 (en) Analyzing large data sets using a computer system
WO2007082757A3 (en) Test systems for the analysis of polypeptides and cells adhering to silicones
TW200702981A (en) Exception analysis methods and systems
WO2010061283A8 (en) Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
EP2176432A4 (en) Method for detecting disease markers
WO2008030186A8 (en) Diagnostic biomolecule(s)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08806500

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 12680347

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008806500

Country of ref document: EP